← Back to Conditions

Pyoderma gangrenosum

disorder
SNOMED 74578003CUI C0085652

Overview

Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Research Evidence

Peer-reviewed studies linked via MeSH term "Pyoderma Gangrenosum" from the MEDLINE/PubMed database.

Sort:
Pyoderma Gangrenosum in Pregnancy: A Systematic Review of Clinical Characteristics, Treatment Outcomes, and Maternofetal Implications.
[object Object], [object Object], [object Object] et al. · J Drugs Dermatol · 2025
PMID: 40627582Meta-Analysis
A Systematic Review of Mendelian Pyoderma Gangrenosum: Clinical and Genetic Characteristics in 120 Published Patients.
[object Object], [object Object], [object Object] et al. · Exp Dermatol · 2025
PMID: 40329681Meta-Analysis
Postsurgical Pyoderma Gangrenosum in Breast Surgery: An Updated Systematic Review, Takeaways, and the 6 Commandments.
[object Object], [object Object], [object Object] et al. · Aesthet Surg J · 2025
PMID: 40417872Meta-Analysis
Treatments for Pyoderma Gangrenosum: A Systematic Review and Single-Arm Meta-Analysis of Systemic Therapies.
[object Object], [object Object], [object Object] et al. · Int Wound J · 2025
PMID: 40740034Meta-AnalysisFull text (PMC)
Outcomes and Risk Factors of Pyoderma Gangrenosum After Reduction Mammoplasty: A Systematic Review of the Literature and Case Report.
[object Object], [object Object], [object Object] et al. · Aesthetic Plast Surg · 2025
PMID: 40389731Meta-AnalysisFull text (PMC)
Management of pyoderma gangrenosum during pregnancy and breastfeeding: a systematic review.
[object Object], [object Object], [object Object] et al. · Int J Dermatol · 2025
PMID: 39086027Meta-Analysis
Evaluation of Inclusion and Exclusion Criteria for Pyoderma Gangrenosum in Clinical Research: A Systematic Review.
[object Object], [object Object], [object Object] et al. · Dermatology · 2024
PMID: 37879301Meta-Analysis
Use of biologic therapies in the management of pyoderma gangrenosum: a systematic review.
[object Object], [object Object], [object Object] et al. · Arch Dermatol Res · 2024
PMID: 39158753Meta-Analysis
Association between pyoderma gangrenosum and autoimmune connective tissue disorders: A systematic review.
[object Object], [object Object], [object Object] et al. · Int J Dermatol · 2024
PMID: 38402537Meta-Analysis
Investigating historic cases of pyoderma gangrenosum in myelodysplastic syndrome and chronic myelomonocytic leukemia for possible VEXAS syndrome: A systematic review.
[object Object], [object Object], [object Object] et al. · J Am Acad Dermatol · 2024
PMID: 38906261Meta-Analysis

Signs & Symptoms

Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.

Arthralgias
Very frequent (80-99%)HP:0002829
Muscle inflammation
Very frequent (80-99%)HP:0100614
Muscle pain
Very frequent (80-99%)HP:0003326
Open skin sore
Very frequent (80-99%)HP:0200042
Papules
Very frequent (80-99%)HP:0200034
Pyrexia
Very frequent (80-99%)HP:0001945
Hypergammaglobulinaemia
Frequent (30-79%)HP:0010702
Hypoplastic myelodysplasia
Frequent (30-79%)HP:0002863
Inflammatory bowel disease
Frequent (30-79%)HP:0002037
Myeloid leukaemia
Frequent (30-79%)HP:0012324
Pustules
Frequent (30-79%)HP:0200039
Rheumatoid arthritis
Frequent (30-79%)HP:0001370
Thin, atrophic scars
Frequent (30-79%)HP:0001075
Abnormal blistering of the skin
Occasional (5-29%)HP:0008066
Skin vesicle
Occasional (5-29%)HP:0200037

Quick Facts

SNOMED CT
74578003
UMLS CUI
C0085652
Fully Specified Name
Pyoderma gangrenosum (disorder)
Specialists
0
Diagnostic Biomarkers
0
HPO Phenotypes
15
Known Treatments
2
Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.